Diallyl Trisulfide
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Diallyl Trisulfide
Description :
Diallyl Trisulfide is an orally active anticancer agent that can be isolated from garlic. Diallyl Trisulfide has the ability to induce apoptosis and exhibits anticancer, anti-inflammatory, antioxidant, and antibacterial activities. Diallyl Trisulfide can be used to study a variety of cancers, including liver, colon and prostate cancer[1][2][3][4].Product Name Alternative :
2-Amino-4-phosphonobutyric acidUNSPSC :
12352100Hazard Statement :
H301Target :
Apoptosis; Bcl-2 Family; Fungal; Influenza Virus; Interleukin Related; Reactive Oxygen Species (ROS) ; SODType :
Natural ProductsRelated Pathways :
Anti-infection; Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κBApplications :
COVID-19-immunoregulationField of Research :
Cancer; Infection; Inflammation/ImmunologyAssay Protocol :
https://www.medchemexpress.com/diallyl-trisulfide.htmlPurity :
99.9Solubility :
DMSO : 100 mg/mL (ultrasonic)Smiles :
C=CCSSSCC=CMolecular Formula :
C6H10S3Molecular Weight :
178.34Precautions :
H301References & Citations :
[1]Pu Liu, et al. Diallyl trisulfide (DATS) effectively induced apoptosis of postharvest diseasePenicillium expansum of citrus. Annals of Microbiology. December 2009, Volume 59, Issue 4, pp 675-679.|[2]Li W, et al. Diallyl trisulfide induces apoptosis and inhibits proliferation of A549 cells in vitro and in vivo. Acta Biochim Biophys Sin (Shanghai) . 2012 Jul;44 (7) :577-83. |[3]Zhang F, et al. Diallyl trisulfide inhibits naphthalene-induced oxidative injury and the production of inflammatory responses in A549 cells and mice. Int Immunopharmacol. 2015 Dec;29 (2) :326-333.|[4]Ming L, et al. Antiviral activity of diallyl trisulfide against H9N2 avian influenza virus infection in vitro and in vivo. Virol J. 2021 Aug 19;18 (1) :171.Shipping Conditions :
Blue IceStorage Conditions :
-20°C (Powder, stored under nitrogen)Scientific Category :
Natural ProductsClinical Information :
No Development ReportedIsoform :
IL-6; IL-8CAS Number :
[2050-87-5]

